ARCHIVES

Cancer Program Critics Called “Irresponsible,” Demagogues”

This article is from The Cancer Letter archive.

Vol. 01 No. 12 | March 21, 1975

Download PDF Visit The Full Archive

Related Articles

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

November 16, 2012

NCI Gets Out of the News Business

January 25, 2013

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012

Improved Therapies For Cervical Cancer Said To Show Promise In Clinical Trials

March 26, 2004